CalciMedica is trading at $1.17, up 10.08%; a broad biotech rally is the likeliest context, with no verified company-specific announcement dated October 21, 2026, explaining the move.
- The XBI is up 2.10%, amid Merck’s acquisition of Silence Therapeutics and positive clinical-trial news.
- CalciMedica appeared among healthcare premarket gainers, though that report quoted a different price. The company’s CFO resignation was reported several days earlier.